A new study suggests that women using menopause hormone therapy alongside GLP-1 medications like Wegovy may experience greater weight loss.
When I started hormone therapy, I was told that the feminization of my body would progress slowly.I also thought that it ...
Blavity on MSN
What to know before asking your doctor about hormone replacement therapy for menopause mood swings
Hot flashes and night sweats usually dominate the conversation around the menopausal transition, but the shifts occurring ...
Heidi Borst is a writer, editor and certified nutrition coach who loves health and wellness. Before joining Forbes Health as a Staff Writer, her work appeared in The New York Times, The Washington ...
Everyday Health on MSN
Combining Hormone Therapy With GLP-1s May Boost Weight Loss for Menopausal Women
Results from a large real-world study suggest hormone therapy may boost weight loss for postmenopausal women taking the GLP-1 ...
The success stories of GLP-1 weight-loss medications are dominating the airwaves. Midlife women, who commonly experience weight gain resulting from menopause, have been especially drawn to the drugs.
Have you noticed that your interest in sex changes at different points of your menstrual cycle? You may feel more interested in sex at one time of the month and less interested around your period.
While adjusting HRT is a routine part of care, many women suffer in silence when symptoms resurface or new issues arise. Be ...
The other day, I received the following question from someone who read my paid article."Is it really possible to get a ...
Learn how environmental toxins may affect your body and discover practical steps to help protect your hormonal health. Our bodies rely on our endocrine system to regulate essential processes, from ...
Please provide your email address to receive an email when new articles are posted on . ACP recommends estrogen, either in combination with progestogen or estrogen monotherapy, for vasomotor symptoms.
Menopausal hormone therapy is recommended as first-line treatment for vasomotor symptoms. Certain serotonin–norepinephrine reuptake inhibitors (SNRIs) are second-line treatments and certain selective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results